The medical therapy of angina pectoris.
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 1997 |
| Tipo de documento: | Artigo |
| Idioma: | por |
| Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2414 |
Resumo: | The angina pectoris crisis should be treated with nitroglycerin S.L.. In our days as in the 19th century, the non pharmacological therapeutic approach for angina pectoris (per se and to improve the free interval between crises) is still the same. This consists of the reduction of mental and physical stress, to stop smoking, improve light exercise, reduce obesity, and control other risk factors for coronary disease. Beta blockers are the choice drugs followed by calcium antagonists and nitrates. It is recommended that no short action calcium antagonists be used. Nitrates must be given with free intervals of action to avoid tachyphylaxis. The anti-platelet therapy can not be forgotten with aspirin or ticlopidine. Patients with refractory angina pectoris should be coronariography for performed eventual revascularization process. |
| id |
RCAP_af7c0228318173946854dacd2adb8c49 |
|---|---|
| oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/2414 |
| network_acronym_str |
RCAP |
| network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| repository_id_str |
7160 |
| spelling |
The medical therapy of angina pectoris.A terapêutica médica da angina de peito.The angina pectoris crisis should be treated with nitroglycerin S.L.. In our days as in the 19th century, the non pharmacological therapeutic approach for angina pectoris (per se and to improve the free interval between crises) is still the same. This consists of the reduction of mental and physical stress, to stop smoking, improve light exercise, reduce obesity, and control other risk factors for coronary disease. Beta blockers are the choice drugs followed by calcium antagonists and nitrates. It is recommended that no short action calcium antagonists be used. Nitrates must be given with free intervals of action to avoid tachyphylaxis. The anti-platelet therapy can not be forgotten with aspirin or ticlopidine. Patients with refractory angina pectoris should be coronariography for performed eventual revascularization process.The angina pectoris crisis should be treated with nitroglycerin S.L.. In our days as in the 19th century, the non pharmacological therapeutic approach for angina pectoris (per se and to improve the free interval between crises) is still the same. This consists of the reduction of mental and physical stress, to stop smoking, improve light exercise, reduce obesity, and control other risk factors for coronary disease. Beta blockers are the choice drugs followed by calcium antagonists and nitrates. It is recommended that no short action calcium antagonists be used. Nitrates must be given with free intervals of action to avoid tachyphylaxis. The anti-platelet therapy can not be forgotten with aspirin or ticlopidine. Patients with refractory angina pectoris should be coronariography for performed eventual revascularization process.Ordem dos Médicos1997-04-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2414oai:ojs.www.actamedicaportuguesa.com:article/2414Acta Médica Portuguesa; Vol. 10 No. 4 (1997): Abril; 287-91Acta Médica Portuguesa; Vol. 10 N.º 4 (1997): Abril; 287-911646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2414https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2414/1829Clara, J Ginfo:eu-repo/semantics/openAccess2022-12-20T11:00:31Zoai:ojs.www.actamedicaportuguesa.com:article/2414Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:17:44.162800Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
| dc.title.none.fl_str_mv |
The medical therapy of angina pectoris. A terapêutica médica da angina de peito. |
| title |
The medical therapy of angina pectoris. |
| spellingShingle |
The medical therapy of angina pectoris. Clara, J G |
| title_short |
The medical therapy of angina pectoris. |
| title_full |
The medical therapy of angina pectoris. |
| title_fullStr |
The medical therapy of angina pectoris. |
| title_full_unstemmed |
The medical therapy of angina pectoris. |
| title_sort |
The medical therapy of angina pectoris. |
| author |
Clara, J G |
| author_facet |
Clara, J G |
| author_role |
author |
| dc.contributor.author.fl_str_mv |
Clara, J G |
| description |
The angina pectoris crisis should be treated with nitroglycerin S.L.. In our days as in the 19th century, the non pharmacological therapeutic approach for angina pectoris (per se and to improve the free interval between crises) is still the same. This consists of the reduction of mental and physical stress, to stop smoking, improve light exercise, reduce obesity, and control other risk factors for coronary disease. Beta blockers are the choice drugs followed by calcium antagonists and nitrates. It is recommended that no short action calcium antagonists be used. Nitrates must be given with free intervals of action to avoid tachyphylaxis. The anti-platelet therapy can not be forgotten with aspirin or ticlopidine. Patients with refractory angina pectoris should be coronariography for performed eventual revascularization process. |
| publishDate |
1997 |
| dc.date.none.fl_str_mv |
1997-04-30 |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2414 oai:ojs.www.actamedicaportuguesa.com:article/2414 |
| url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2414 |
| identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/2414 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2414 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2414/1829 |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
| publisher.none.fl_str_mv |
Ordem dos Médicos |
| dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 10 No. 4 (1997): Abril; 287-91 Acta Médica Portuguesa; Vol. 10 N.º 4 (1997): Abril; 287-91 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
| instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
| instacron_str |
RCAAP |
| institution |
RCAAP |
| reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
| repository.mail.fl_str_mv |
|
| _version_ |
1799130630656622592 |